. Mutant p53-expressing cells display limited retrograde actin flow at the leading edge. (A) A2780 cells transiently transfected with Lifeact-mRFPmars and paGFP-Actin or paGFP were seeded onto glass-bottomed dishes 24 h before imaging and treated with cRGDfV (2.5 µM, 2 h) as indicated. ROI1 was photoactivated and cells were imaged every second for 100 s. Normalized intensity was analyzed for ROI1 and ROI2 n = 21; +cRGDfV, n = 20) . Insets show enlarged views of the boxed regions. (B) H1299-Vec and H1299-p53-273H cells transfected as in A were seeded onto glass-bottomed dishes 24 h before imaging. Photoactivation was performed as in A (VEC, n = 15; p53-273H, n = 10). (C) MDA-MB-231 cells transfected as in A were seeded onto CDM-coated glass-bottomed dishes 4 h before imaging. Photoactivation was performed as in A (n = 10). Yellow arrows indicate the direction of protrusion. Yellow broken lines mark the center of the photoactivated region. Error bars represent SEM. All data represent at least three independent experiments. Blue bars indicate time points at which -or +cRGDfV or mutant p53 datasets are significantly different (P < 0.01; Student's t test). Figure S2 . Mutant p53-expressing cells generate bursts of actin spikes. (A-C) H1299-Vec (A), H1299-p53-273H (B), or MDA-MB-231 (C) cells transiently transfected with Lifeact-mEGFP were seeded onto CDMs for 4 h and imaged using a spinning disk confocal microscope every minute for≥25 min. Z projections are shown. White arrowheads indicate lamellipodial protrusions; red arrowheads indicate actin spikes. The white boxed regions are enlarged on the right, and the kymograph images are taken from the yellow boxed regions. (D) A2780 cells transfected with Lifeact-mEGFP were seeded onto CDMs for 4 h and imaged using a spinning disk confocal microscope every minute for 15 min, and filopodia lifetime was analyzed. n = 8 cells per condition. All data represent at least three independent experiments. Statistical significance was evaluated using a Student's t test with Welch's correction. +, mean; *, P < 0.05. Fig. 3 C) . n ≥ 99 cells per condition. (J) Distance from the rear of the cell to the center of the nucleus of siCtrl and siArpC2 A2780 cells migrating in CDM. n = 100 cells per condition. (K) α5 integrin recycling in A2780 cells was measured upon treatment with CK-666 or CK-689 (50 µM). n = 24 wells over three experiments. (L and M) GFP-RCP-transfected A2780 cells were seeded onto CDMs for 4 h before treatment with cRGDfV (2.5 µM), CK-666, or CK-689 (50 µM) as indicated before confocal imaging. Bounding boxes around the cell perimeter (yellow) were used to identify the front and rear quarter (green or red, respectively) of the cell, and the percentage of GFP-RCP intensity at the front was measured (M). Insets show enlarged views of the white boxed regions. n = 15-28 cells per condition. All data represent at least three independent experiments. Statistical significance was evaluated using ANOVA/Tukey's multiple comparison test. +, mean; n.s., not significant; *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001. Figure S4 . FHOD3 is required for 3D (but not 2D) migration. (A) Percentage knockdown of formins expressed in A2780 cells by siRNA, measured by qRT-PCR. n = 2-3 per condition. (B) A2780 cells were stably transfected with pLVTHM vector control, shFHOD3 #1, or shFHOD3 #2. shFHOD3 #1 was rescued with sh-resistant RFP-FHOD3. FHOD3 gene expression was measured by qRT-PCR. Fold change in gene expression is given relative to pLVTHM vector control. n = 3-6 independent experiments. (C) A2780 cells stably expressing pLVTHM vector control, shFHOD3 #1, or shFHOD3 #2 were seeded onto tissue culture plates 24 h before wounding. Cells were treated with cRGDfV (2.5 µM) as indicated before time-lapse imaging. (D and E) Quantification of 2D migration speed, directional persistence (D), and autocorrelation (E). n = 45-70 cells per condition. (F) A2780 cells stably expressing shFHOD3 #1, shFHOD3 #2, pLVTHM vector control, or RFP-FHOD3 rescue were seeded onto CDM and treated with cRGDfV (2.5 µM) where indicated before time-lapse imaging, and MSD was quantified. n = 96-134 cells per condition. (G) RNA extracted from cell lines as indicated was used as to determine FHOD3 isoforms expressed by RT-PCR, using primers specific for nonmuscle and muscle-specific isoforms of FHOD3 (pan FHOD3, to yield products at 478 bp and 502 bp, respectively) or muscle-specific FHOD3 primers (to yield a product at 316 bp). All data represent at least three independent experiments. Statistical significance was evaluated using ANOVA/Tukey's multiple comparison test. +, mean; n.s., not significant; **, P < 0.01; ****, P < 0.0001. Error bars represent the SEM. Figure S5 . Wild-type FHOD3 localizes to actin filaments in 3D CDM; active FHOD3 localizes to actin spikes in 3D CDM. (A) A2780 cells stably expressing RFP or RFP-FHOD3 were seeded onto CDMs for 4 h and treated with cRGDfV (2.5 µM) where indicated. Cells were fixed and stained with anti-RFP antibody and Alexa Fluor 647-conjugated phalloidin before wide-field fluorescence imaging. Arrows indicate localization of RFP-FHOD3 on actin filaments. (B) A2780 cells were transiently transfected with GFP or GFP-FHOD3ΔDAD, seeded onto CDMs for 4 h, and treated with cRGDfV (2.5 µM) where indicated. Cells were fixed and stained with TRITC-phalloidin before spinning disk confocal imaging. Arrowheads indicate colocalization of actin spikes and GFP-FHOD3ΔDAD. Boxes with broken lines indicate the line profile intensity measurements in C. (D) H1299-273H cells were stably transfected with pLVTHM vector control, shFHOD3 #1, or shFHOD3 #2. Cells were lysed, and lysates were subjected to SDS-PAGE and Western blotting using antibodies specific for FHOD3 and α-tubulin. All data represent at least three independent experiments.
